Last $14.52 HKD
Change Today -0.14 / -0.95%
Volume 56.0K
8058 On Other Exchanges
Symbol
Exchange
Hong Kong
OTC US
OTC US
As of 11:05 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

shandong luoxin pharmaceut-h (8058) Snapshot

Open
$14.66
Previous Close
$14.66
Day High
$14.86
Day Low
$14.18
52 Week High
11/14/14 - $18.38
52 Week Low
01/2/14 - $6.56
Market Cap
8.9B
Average Volume 10 Days
217.8K
EPS TTM
$0.66
Shares Outstanding
164.6M
EX-Date
06/3/14
P/E TM
17.7x
Dividend
$0.30
Dividend Yield
2.56%
Current Stock Chart for SHANDONG LUOXIN PHARMACEUT-H (8058)

Related News

No related news articles were found.

shandong luoxin pharmaceut-h (8058) Related Businessweek News

No Related Businessweek News Found

shandong luoxin pharmaceut-h (8058) Details

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is engaged in the manufacture and sale of pharmaceutical products in the People’s Republic of China. It is also involved in the manufacture and wholesale of biochemical products and Chinese medicine. The company was formerly known as Shandong Luoxin Pharmacy Stock Co., Ltd. and changed its name to Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. in August 2014. The company was founded in 1995 and is based in Linyi, China. Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a subsidiary of Luoxin Pharmacy Group Co., Ltd.

Founded in 1995

shandong luoxin pharmaceut-h (8058) Top Compensated Officers

Chief Executive Officer, Head of Research & D...
Total Annual Compensation: CNY120.0K
Executive Director
Total Annual Compensation: CNY48.0K
Secretary of the Board and Executive Director
Total Annual Compensation: CNY60.0K
Vice General Manager of Production Department...
Total Annual Compensation: CNY60.0K
Manager of Bulk Medicine Workshop and Supervi...
Total Annual Compensation: CNY60.0K
Compensation as of Fiscal Year 2013.

shandong luoxin pharmaceut-h (8058) Key Developments

Shandong Luoxin Pharmacy Stock Co. Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Shandong Luoxin Pharmacy Stock Co. Ltd. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, turnover was RMB 657,915,000 against RMB 624,891,000 a year ago. Profit before taxation was RMB 107,785,000 against RMB 114,169,000 a year ago. Profit attributable to owners of the company was RMB 88,275,000 or 14.49 cents per basic and diluted share against RMB 97,454,000 or 15.99 cents per basic and diluted share a year ago. For the nine months, turnover was RMB 1,995,735,000 against RMB 1,768,456,000 a year ago. Profit before taxation was RMB 373,422,000 against RMB 395,525,000 a year ago. Profit attributable to owners of the company was RMB 309,971,000 or 50.85 cents per basic and diluted share against RMB 336,371,000 or 55.18 cents per basic and diluted share a year ago. The increase in turnover was attributable to the Group's launch of products with high added-values, an upgrade of the Group's product portfolio and the acceleration of sales network development to increase the market share of its products. Weighted average earnings per share amounted to RMB 0.51 for the nine months ended 30 September 2014.

Shandong Luoxin Pharmacy Stock Co., Ltd Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Shandong Luoxin Pharmacy Stock Co. Ltd. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, turnover was RMB 694,490,000 against RMB 525,028,000 a year ago. Profit before taxation was RMB 116,381,000 against RMB 126,610,000 a year ago. Profit attributable to owners of the company was RMB 99,759,000 or 16.36 cents per basic and diluted share against RMB 108,609,000 or 17.81 cents per basic and diluted share a year ago. For the six months, turnover was RMB 1,337,820,000 against RMB 1,143,565,000 a year ago. The increase was attributable to the Group's launch of products with high added-values, an upgrade of the Group's product portfolio and the acceleration of sales network development to increase the market share of its products. Profit before taxation was RMB 265,637,000 against RMB 281,356,000 a year ago. Profit attributable to owners of the company was RMB 221,696,000 or 36.36 cents per basic and diluted share against RMB 238,917,000 or 39.19 cents per basic and diluted share a year ago. Net cash inflow from operating activities was RMB 263,509,000 against RMB 275,309,000 a year ago.

Shandong Luoxin Pharmacy Stock Co., Ltd to Report First Half, 2014 Results on Aug 05, 2014

Shandong Luoxin Pharmacy Stock Co., Ltd announced that they will report first half, 2014 results on Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8058:HK $14.52 HKD -0.14

8058 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8058.
View Industry Companies
 

Industry Analysis

8058

Industry Average

Valuation 8058 Industry Range
Price/Earnings 17.4x
Price/Sales 2.5x
Price/Book 3.3x
Price/Cash Flow 17.4x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG LUOXIN PHARMACEUT-H, please visit www.luoxin.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.